Veterinary Medicines

Torphadine 10 mg/ml Solution for Injection for Dogs, Cats and Horses

Authorised
  • Butorphanol tartrate
Download as PDF

Product identification

Medicine name:
Torphadine 10 mg/ml Solution for Injection for Dogs, Cats and Horses
Torphadine 10 mg/ml Solution for Injection for Dogs, Cats and Horses
Active substance:
  • Butorphanol tartrate
Target species:
  • Horse
  • Dog
  • Cat
Route of administration:
  • Intramuscular use
  • Intravenous use
  • Subcutaneous use

Product details

Active substance and strength:
  • Butorphanol tartrate
    14.58
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Horse
      • Meat and offal
        no withdrawal period
    • Dog
    • Cat
  • Intravenous use
    • Horse
      • Meat and offal
        no withdrawal period
    • Dog
    • Cat
  • Subcutaneous use
    • Horse
      • Meat and offal
        no withdrawal period
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN02AF01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • United Kingdom (Northern Ireland)
Package description:
  • Clear type I glass vial of 20 ml closed with a coated bromobutyl rubber stopper and aluminium cap in a carton box
  • Clear type I glass vial of 10 ml closed with a coated bromobutyl rubber stopper and aluminium cap in a carton box

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Le Vet. Beheer B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Produlab Pharma B.V.
Responsible authority:
  • The Veterinary Medicines Directorate
Authorisation number:
  • Vm 41821/4037
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0316/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."